Home > Healthcare > Drug Device Combination > Drug Filled Devices > Mucosal Atomization Device Market

Mucosal Atomization Device Market Size

  • Report ID: GMI9181
  • Published Date: Apr 2024
  • Report Format: PDF

Mucosal Atomization Device Market Size

Mucosal Atomization Device Market size was valued at USD 712.3 million in 2023 growing at a CAGR of 7.4% between 2024 and 2032. The market growth is being fuelled by several key factors, including the rising prevalence of respiratory illnesses, expanding adoption of intranasal drug delivery systems, and a surging demand for safer and pain-free medication administration solution. Furthermore, the ease of handling and precise drug delivery facilitated by mucosal atomization devices are bolstering market expansion efforts.


With the increasing prevalence of respiratory conditions such as chronic sinusitis, allergic rhinitis, asthma, and respiratory infections, there is a growing need for effective delivery methods for respiratory medications. Mucosal atomization devices provide a targeted medication delivery method that directly applies the drugs to the respiratory mucosa, enhancing the treatment results for patients with respiratory conditions. According to a study published in National Library of Medicine in April 2022, prevalence of allergic rhinitis has increased globally since the 1990 affecting about 400 million people worldwide yearly.


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Mucosal atomization device industry size recorded over USD 712.3 million in 2023 and is expected to depict 7.4% CAGR from 2024 to 2032, owing to the rising prevalence of respiratory illnesses, and the expanding adoption of intranasal drug delivery systems

The nasal atomization devices segment in the market accumulated 36.6% share in 2023 and is estimated to grow at substantial CAGR between 2024 and 2032, on account of the surging incidences of respiratory illness.

North America mucosal atomization device industry is projected to be worth USD 498.9 million by 2032, due to the robust presence of advanced healthcare facilities, high demand for non-invasive drug delivery solutions, and the increasing cases of respiratory illness.

Becton, Dickinson, and Co., BTME Group Ltd. (Medtree), BVM Meditech Pvt. Ltd., Cook Medical, Inc., DeVilbiss Healthcare LLC, Intersurgical Ltd., Kurve Therapeutics, Life-Assist Inc., Medica Holdings, LLC, Medspray, Pulmodyne, Inc., and Teleflex Inc. are some of the leading mucosal atomization device companies worldwide.

Mucosal Atomization Device Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 291
  • Countries covered: 22
  • Pages: 190
 Download Free Sample